Company: HURA
Filing Date: 2025-11-03
Form Type: S-3
Source: 0001193125-25-262843
Chunk: 2

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-03
Form: S-3
Chunk 2
---
 and sold under a Sales Agreement with H.C. Wainwright & Co., LLC. |

The base prospectus immediately follows this explanatory note. The specific terms of any securities to be offered pursuant to the base prospectus will be specified in a prospectus supplement to the base prospectus. The specific terms of the securities to be issued and sold under the Sales Agreement are specified in the ATM prospectus supplement that immediately follows the base prospectus. The $50,000,000 of Common Stock that may be offered, issued and sold under the ATM prospectus supplement is included in the $250,000,000 of securities that may be offered, issued and sold by us under the base prospectus. Upon termination of the Sales Agreement with H.C. Wainwright & Co., LLC, any portion of the $50,000,000 included in the ATM prospectus supplement that is not sold pursuant to the Sales Agreement will be available for sale in other offerings pursuant to the base prospectus and a corresponding prospectus supplement, and if no shares are sold under the Sales Agreement, the full $50,000,000 of securities may be sold in other offerings by us pursuant to the base prospectus and a corresponding prospectus supplement, subject to any applicable limitations set forth herein and therein. The registrant filed a registration statement on Form S-1(File No. 333-289532)with the Securities and Exchange Commission on August 12, 2025, which was declared effective on September 26, 2025 (the “Prior Registration Statement”). The Prior Registration Statement registered for resale by certain selling stockholders up to (i) 4,570,629 shares of our Common Stock and (ii) 4,750,916 shares of our Common Stock issuable upon the exercise of warrants related to a previous private placement (the “Resale”). As of the date of the filing of this registration statement, all of the shares of Common Stock and shares of Common Stock issuable upon the exercise of warrants under the Prior Registration Statement with respect to the Resale remained unsold (the “Unsold Securities”). Pursuant to Rule 415(a)(5) under the Securities Act of 1933, as amended (the “Securities Act”), the registrant intends to continue to offer and sell the Unsold Securities under the Prior Registration Statement until the date on which this registration statement is declared effective by the Securities and Exchange Commission (the “Expiration Date”). Until the Expiration Date, the registrant may continue to use the